[HTML][HTML] Solid lipid nanoparticles: Emerging colloidal nano drug delivery systems

V Mishra, KK Bansal, A Verma, N Yadav, S Thakur… - Pharmaceutics, 2018 - mdpi.com
Solid lipid nanoparticles (SLNs) are nanocarriers developed as substitute colloidal drug
delivery systems parallel to liposomes, lipid emulsions, polymeric nanoparticles, and so …

[HTML][HTML] Solid lipid nanoparticles (SLNs): an advanced drug delivery system targeting brain through BBB

MK Satapathy, TL Yen, JS Jan, RD Tang, JY Wang… - Pharmaceutics, 2021 - mdpi.com
The blood–brain barrier (BBB) plays a vital role in the protection and maintenance of
homeostasis in the brain. In this way, it is an interesting target as an interface for various …

PI3K/AKT/mTOR pathway inhibitors in triple-negative breast cancer: a review on drug discovery and future challenges

MA Khan, VK Jain, M Rizwanullah, J Ahmad, K Jain - Drug discovery today, 2019 - Elsevier
Highlights•TNBC represents the most aggressive phenotype of breast cancer.•Conventional
therapy prescribed for breast cancer is not effective in treatment of TNBC.•Specific …

Solid lipid nanoparticles as attractive drug vehicles: Composition, properties and therapeutic strategies

M Geszke-Moritz, M Moritz - Materials Science and Engineering: C, 2016 - Elsevier
This work briefly reviews up-to-date developments in solid lipid nanoparticles (SLNs) as
effective nanocolloidal system for drug delivery. It summarizes SLNs in terms of their …

Chitosan-based nanoparticles: An overview of biomedical applications and its preparation

S Naskar, S Sharma, K Kuotsu - Journal of Drug Delivery Science and …, 2019 - Elsevier
Chitosan (CS) is one of the most successfully developed biodegradable polymers. Among
the numerous polymers developed to formulate polymeric nanoparticles, CS has fascinated …

Chitosan-based nanoparticles as drug delivery systems: a review on two decades of research

S Naskar, K Kuotsu, S Sharma - Journal of drug targeting, 2019 - Taylor & Francis
Chitosan (CS) is one of the most functional natural biopolymer widely used in the
pharmaceutical field due to its biocompatibility and biodegradability. These privileges lead …

[HTML][HTML] Chitosan nanoparticles as oral drug carriers

OR Guadarrama-Escobar… - International journal of …, 2023 - mdpi.com
The use of nanoparticles as drug delivery systems has increased in importance in the last
decades. Despite the disadvantages of difficulty swallowing, gastric irritation, low solubility …

[HTML][HTML] Nanoparticles: New agents toward treatment of leishmaniasis

A Nafari, K Cheraghipour, M Sepahvand… - Parasite epidemiology …, 2020 - Elsevier
Leishmaniasis is a widespread disease that causes 20,000 to 30,000 deaths annually,
making it a major health problem in endemic areas. Because of low-performance …

Preparation, characterization, and pharmacological application of oral Honokiol-loaded solid lipid nanoparticles for diabetic neuropathy

T Bibi, S Bano, F ud Din, H Ali, S Khan - International Journal of …, 2023 - Elsevier
Honokiol is a phytochemical component with a variety of pharmacological properties.
However, the major limitation of Honokiol is its poor solubility and low oral bioavailability. In …

[HTML][HTML] Current status of nanoscale drug delivery and the future of nano-vaccine development for leishmaniasis–A review

P Prasanna, P Kumar, S Kumar, VK Rajana… - Biomedicine & …, 2021 - Elsevier
The study of tropical diseases like leishmaniasis, a parasitic disease, has not received much
attention even though it is the second-largest infectious disease after malaria. As per the …